VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure May 4, 2024 — 18:00
Chinese new energy industry contributes to global green, low-carbon transition April 30, 2024 — 15:13
Nature’s Miracle Announces Initial Shipments of the "MiracleTainer" Series Container Farm April 25, 2024 — 23:30
Terra Drone, Unifly, and Aloft Technologies Launch UTM Development for AAM Targeting Global Markets April 25, 2024 — 07:00